Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomised, double-blind, placebo-controlled trial examining the dose-dependent effects of acute alcohol intoxication on neurocognitive performance.

Psychopharmacology·2026
Same author

We Are What We Do: Trait and Ability Emotional Intelligence as Predictors of Adolescent Resilience.

Psychological reports·2026
Same author

Correction: Loughran et al. Radiofrequency Electromagnetic Field Exposure and the Resting EEG: Exploring the Thermal Mechanism Hypothesis. <i>Int. J. Environ. Res. Public Health</i> 2019, <i>16</i>, 1505.

International journal of environmental research and public health·2026
Same author

Effects of prescribed medical cannabis and alcohol on real-world driving performance (CAN-TRACK): a study protocol for a two-phase trial.

Trials·2026
Same author

Attitudes and behaviours on driving under the influence of drugs: a multigroup analysis of non-drug users and people who use methamphetamine.

Harm reduction journal·2026
Same author

Pursuit of Happiness: The Relationship Between Adolescent Wellbeing, Psychological Distress, Problem Behaviours, and Emotional Intelligence.

Psychological reports·2025

Related Experiment Video

Updated: May 24, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

The effect of d-methamphetamine on simulated driving performance.

Beata Y Silber1, Rodney J Croft, Luke A Downey

  • 1Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, Victoria, Australia.

Human Psychopharmacology
|March 6, 2012
PubMed
Summary

This study found that a moderate dose of d-methamphetamine did not significantly impair simulated driving performance. However, drivers under the influence drove slower in emergencies and showed a trend towards running more red lights.

More Related Videos

Neurotoxicity Assessment in Adult Danio rerio using a Battery of Behavioral Tests in a Single Tank
08:36

Neurotoxicity Assessment in Adult Danio rerio using a Battery of Behavioral Tests in a Single Tank

Published on: November 3, 2023

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research
07:15

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Published on: December 18, 2020

Related Experiment Videos

Last Updated: May 24, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Neurotoxicity Assessment in Adult Danio rerio using a Battery of Behavioral Tests in a Single Tank
08:36

Neurotoxicity Assessment in Adult Danio rerio using a Battery of Behavioral Tests in a Single Tank

Published on: November 3, 2023

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research
07:15

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Published on: December 18, 2020

Area of Science:

  • Neuroscience
  • Forensic Science
  • Psychopharmacology

Background:

  • Methamphetamine is a commonly abused drug by drivers, yet its precise impact on driving behavior remains under-researched.
  • Epidemiological data suggest a link between methamphetamine use and driving impairment, evidenced by its prevalence in impaired driving incidents.

Purpose of the Study:

  • To investigate the effects of a controlled dose of d-methamphetamine on simulated driving performance and behavior.
  • To compare driving performance under d-methamphetamine versus placebo conditions in recreational stimulant users.

Main Methods:

  • A double-blind, placebo-controlled study involving 20 healthy recreational stimulant users (21-32 years old).
  • Participants underwent two sessions, receiving either 0.42 mg/kg oral d-methamphetamine or a placebo.
  • Simulated driving performance was assessed 2.5 hours post-administration.

Main Results:

  • Overall simulated driving performance was not significantly impaired by d-methamphetamine (0.42 mg/kg).
  • Participants on d-methamphetamine drove slower during simulated emergency situations (p < 0.05).
  • A trend indicated more red light infringements in the d-methamphetamine group (p = 0.11), with both groups exceeding the speed limit in emergencies.

Conclusions:

  • The tested dose of d-methamphetamine did not impair driving performance as much as epidemiological data might suggest.
  • Further research is needed to explore the effects of varying methamphetamine doses and combinations with other substances on driving.
  • The findings highlight a potential discrepancy between controlled study results and real-world driving impairment linked to methamphetamine use.